[Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
作者信息
Dubovik B V, Shadurskiĭ K S, Etlis V S, Lushnikova G A, Shevchuk A S
出版信息
Farmakol Toksikol. 1971 May-Jun;34(3):352-7.
PMID:5568700
Abstract
摘要
相似文献
1
[Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
Farmakol Toksikol. 1971 May-Jun;34(3):352-7.
2
[Animal experimental fundamentals in the medicinal prevention of silicosis using polyvinylpyridine-N-oxide (P204)].
Dtsch Med Wochenschr. 1968 Dec 20;93(51):2479-82. doi: 10.1055/s-0028-1110965.
3
[Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
Gig Sanit. 1973 Apr;38(4):102-4.
4
[Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].
Gig Tr Prof Zabol. 1973 May;17(5):22-5.
5
[Antifibrous action of polyvinyl-pyridine-N-oxides in experimental silicosis].
Gig Tr Prof Zabol. 1973 Dec;17(12):20-4.
6
[Antisilicotic activity of various amides of polymethacrylic acid].
Gig Tr Prof Zabol. 1982 Feb(2):15-7.
7
[Regression of experimental silicotic granuloma under the influence of polyvinylpyridin-N-oxide].
Verh Dtsch Ges Pathol. 1969;53:367-70.
8
[Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
Beitr Silikoseforsch Pneumokoniose. 1971;23(3):91-100.
9
[Polyvinylpyrididine-N-oxide and pulmonary changes in rats powdered with carbon dust].
Z Gesamte Hyg. 1973 Jul;19(7):520-4.
10
[Detoxicating effects of poly-2-vinylpyridine-N-oxide].
Beitr Silikoseforsch Pneumokoniose. 1970;22(3):93-172.
引用本文的文献
1
Poly (2-vinylpyridine 1-oxide) in silicosis therapy: effective molecular weight.
Int Arch Occup Environ Health. 1977;38(3):177-88. doi: 10.1007/BF00378355.
Zotero 插件